We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The 2025 ADA Standards of Care includes updated ...

Clinicians should screen adults with type 2 diabetes or prediabetes for nonalcoholic fatty liver disease (NAFLD), according to a guideline update to the American Diabetes Association’s Standards of ...

ADA: Diabetes rising significantly in U.S. youth From 2001 to 2009, type 1 diabetes prevalence increased 23% and type 2 diabetes prevalence increased 21% among youth aged 10 to 20 years. HealthDay ...

Please provide your email address to receive an email when new articles are posted on . The updates, published as annotations in the Living Standards of Care, include new data on CV outcomes in adults ...

Though continuous glucose monitors have long been more widely used among people with Type 1 diabetes, new research has increasingly shown that the Type 2 population can majorly benefit from CGM use, ...

It may not be able to pass the Turing test, but a “digital twin” created by Twin Health’s artificial intelligence could help its human counterpart reverse the symptoms of Type 2 diabetes and ...

Biomea Fusion presented positive data on icovamenib for type 2 diabetes, showing improved glycemic control and weight loss in clinical trials. Biomea Fusion announced promising new data for icovamenib ...

New State of Type 2 Report in the United States reports that a majority of healthcare professionals (HCPs) surveyed believe continuous glucose monitoring will have the potential to be more impactful ...

Diabetes is one of the leading causes of death and disability in the U.S., states the Centers for Disease Control and Prevention. Around 37.3 million Americans have diabetes, according to the American ...

New guidelines and key studies in glycemic control from the 2022 annual meeting of the American Diabetes Association (ADA) are highlighted by Dr Ildiko Lingvay, from the University of Texas ...

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (DXCM), the global leader in glucose biosensing, today released its "Dexcom State of Type 2 Report: Access and Attitudes Across the United States" ahead of ...